Literature DB >> 3437302

Double-blind evaluation of clonazepam on periodic leg movements in sleep.

R Peled1, P Lavie.   

Abstract

Treatment with clonazepam was studied in a group of 20 patients suffering from periodic movements in sleep, in a double-blind parallel group design. Eleven complained of excessive daytime sleepiness, and nine complained of insomnia. Ten patients received clonazepam, and 10 received placebo, over a period of 1 month. Clonazepam (0.5-2 mg per night) proved to be an effective treatment of periodic movements in sleep. Polysomnographic recordings demonstrated a significant decrease in the number of leg movements and a significant improvement in sleep parameters in the clonazepam group as compared with placebo. Subjective responses to treatment corroborated the sleep laboratory findings.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3437302      PMCID: PMC1032613          DOI: 10.1136/jnnp.50.12.1679

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

1.  Nocturnal myoclonus.

Authors:  C P SYMONDS
Journal:  J Neurol Neurosurg Psychiatry       Date:  1953-08       Impact factor: 10.154

2.  Sleep-related periodic myoclonus in patients complaining of insomnia.

Authors:  C Guilleminault; D Raynal; E D Weitzman; W C Dement
Journal:  Trans Am Neurol Assoc       Date:  1975

3.  Periodic leg movements in sleep: effect of clonazepam treatment.

Authors:  N Ohanna; R Peled; A H Rubin; J Zomer; P Lavie
Journal:  Neurology       Date:  1985-03       Impact factor: 9.910

4.  [Apropos of some nocturnal myoclonic manifestations. (Symonds' nocturnal myoclonus)].

Authors:  E Lugaresi; G Coccagna; D Gambi; G B Ceroni; M Poppi
Journal:  Rev Neurol (Paris)       Date:  1966-09       Impact factor: 2.607

5.  Effect of baclofen on sleep-related periodic leg movements.

Authors:  C Guilleminault; W Flagg
Journal:  Ann Neurol       Date:  1984-03       Impact factor: 10.422

6.  Descriptive epidemiology of Creutzfeldt-Jakob disease in Chile.

Authors:  S Galvez; C Masters; C Gajdusek
Journal:  Arch Neurol       Date:  1980-01

7.  Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorders.

Authors:  R M Coleman; C P Pollak; E D Weitzman
Journal:  Ann Neurol       Date:  1980-10       Impact factor: 10.422

8.  Periodic movements during sleep, sleep fragmentation, and sleep-wake complaints.

Authors:  L Rosenthal; T Roehrs; J Sicklesteel; F Zorick; R Wittig; T Roth
Journal:  Sleep       Date:  1984       Impact factor: 5.849

9.  Periodic movements in sleep and sleep-wake complaint.

Authors:  P Saskin; H Moldofsky; F A Lue
Journal:  Sleep       Date:  1985-12       Impact factor: 5.849

10.  Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam.

Authors:  M M Mitler; C P Browman; S J Menn; K Gujavarty; R M Timms
Journal:  Sleep       Date:  1986       Impact factor: 5.849

  10 in total
  12 in total

1.  Restless Legs Syndrome.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-09       Impact factor: 3.598

Review 2.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

Review 3.  Management of restless legs syndrome in patients on dialysis.

Authors:  Miklos Z Molnar; Marta Novak; Istvan Mucsi
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Recent advances in the diagnosis, genetics and treatment of restless legs syndrome.

Authors:  Claudia Trenkwalder; Birgit Högl; Juliane Winkelmann
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

5.  Restless legs syndrome: a unique case and essentials of diagnosis and treatment.

Authors:  Pinky Agarwal; Alida Griffith
Journal:  Medscape J Med       Date:  2008-12-31

Review 6.  Restless legs and periodic leg movements in sleep syndromes.

Authors:  T C Wetter; T Pollmächer
Journal:  J Neurol       Date:  1997-04       Impact factor: 4.849

Review 7.  Update on Restless Legs Syndrome: from Mechanisms to Treatment.

Authors:  Paulina Gonzalez-Latapi; Roneil Malkani
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-27       Impact factor: 5.081

Review 8.  Clonazepam for the management of sleep disorders.

Authors:  Alberto Raggi; Maria Paola Mogavero; Lourdes M DelRosso; Raffaele Ferri
Journal:  Neurol Sci       Date:  2022-09-16       Impact factor: 3.830

9.  Treatment of sleep disorders in children.

Authors:  Janet C Lam; Thornton B A Mason
Journal:  Curr Treat Options Neurol       Date:  2007-11       Impact factor: 3.598

10.  A Prospective, Randomized, Open-Label Study Comparing the Efficacy and Safety of Clonazepam versus Nortriptyline on Quality of Life in 40+ Years old Women Presenting with Restless Leg Syndrome.

Authors:  Vishal R Tandon; Annil Mahajan; Sudhaa Sharma; Vijay Khajuria
Journal:  J Midlife Health       Date:  2018 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.